Natera shared on LinkedIn:
“Thank you to everyone who stopped by our booth, met our team, and attended our presentations during this year’s American Society of Nephrology Kidney Week.
We, along with our collaborators, presented 18 abstracts, including three oral presentations, featuring real-world analyses from a large database of patients with indicators of kidney disease.
Together, the data underscored how genetic testing can support better care in chronic kidney disease (CKD) and added to the growing evidence behind Renasight, our genetic test for CKD.”
Other articles about American Society of Nephrology and chronic kidney disease on OncoDaily.
